SPP-037
Product Specifications
Target
Endogenous Metabolite|||FAK
Related Pathways
Tyrosine Kinase/Adaptors|||Angiogenesis|||Metabolism|||Cytoskeletal Signaling
Bioactivity
SPP-037 is an orally active selective inhibitor of ST6GAL1, with an IC50 of 3.59 ?M. It exhibits anti-migration activity against MDA-MB-231 cells by inhibiting integrin ?2,6-sialylation and the integrin-FAK-paxillin pathway. In MDA-MB-231 xenograft mouse models, SPP-037 demonstrates antitumor properties. This compound is applicable in breast cancer research.
Molecular Formula
C36H50ClN3O9S
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
